GGrantIndex
Sort

50,496 grants matching lung cancer

Center for Clinical and Translational Sciences (CCTS)

$1,859,600
David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2021 · TR

COHORT STUDY OF DIETARY SUPPLEMENTS AND CANCER RISK

$1,859,452
Fred Hutchinson Cancer Research Center · R01 · FY2000 · CA

The Molecular Pathogenesis of Varicella Zoster Virus Infection

$1,858,372
Maria Acena Nagel · University Of Colorado Denver · P01 · FY2016 · AG

Tumor-Stroma Interacions in the Tumor Microenvironment

$1,854,827
Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2009 · CA

Etiology of Alkylator-Induced Myeloid Leukemia

$1,854,803
Michelle M Le Beau · University Of Chicago · P01 · FY2012 · CA

Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)

$1,854,519
Sanjiv S Gambhir · Stanford University · U54 · FY2015 · CA

Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa

$1,853,980
W. Henry Henry Boom · Case Western Reserve University · R01 · FY2020 · AI

Emory University Lung Cancer SPORE

$1,853,913
Suresh S Ramalingam · Emory University · P50 · FY2019 · CA

Immunometabolism in Cancer and Inflammation

$1,853,481
Daniel W. McVicar · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Clinical Cancer Genomics Program

$1,853,306
Kathleen Calzone · Division Of Basic Sciences - Nci · ZID · FY2024 · CA

New Targets for Therapy for Adenocarcinoma of the Lung

$1,852,570
Mark G Kris · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA

Defining neoantigen immunodominance for antigen selection and biomarker discovery in human pancreatic cancer immunotherapy

$1,850,296
Vinod P Balachandran · Sloan-Kettering Inst Can Research · U01 · FY2017 · CA

Expanding the National Health Accounts

$1,850,167
David M Cutler · National Bureau Of Economic Research · P01 · FY2012 · AG

An Extensible Resource for Genomic Analysis and Petascale Storage

$1,849,685
Harel Weinstein · Weill Medical Coll Of Cornell Univ · S10 · FY2012 · OD

VITamin D and omegA-3 triaL (VITAL)

$1,849,394
Joann Elisabeth Manson · Brigham And Women'S Hospital · U01 · FY2014 · CA

Immunometabolism in Cancer and Inflammation

$1,848,182
Daniel W. McVicar · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

$1,847,127
Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2019 · CA

Mechanisms of Normal Tissue Toxicity From Irradiation

$1,846,567
Deborah Citrin · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

$1,846,248
Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2017 · CA

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

$1,846,173
Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2018 · CA

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

$1,846,173
Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2020 · CA

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

$1,846,173
Matthew L Meyerson · Dana-Farber Cancer Inst · P01 · FY2021 · CA

Center for Immunotherapeutic Transport Oncophysics

$1,845,151
Mauro Ferrari · Methodist Hospital Research Institute · U54 · FY2017 · CA

Systematic interrogation of the pancreatic cancer microenvironment in patient-derived specimens

$1,845,039
William C Hahn · Dana-Farber Cancer Inst · U01 · FY2017 · CA

Mechanisms of non-classical multidrug resistance in cancer

$1,844,598
Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA